Stocklytics Platform
Asset logo for symbol SNTI
Senti Biosciences
SNTI53
$3.93arrow_drop_up1.02%$0.04
Penny Stock
Asset logo for symbol SNTI
SNTI53

$3.93

arrow_drop_up1.02%

Performance History

Chart placeholder
Key Stats
Open$3.95
Prev. Close$3.90
EPS-15.59
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$18.03M
PE Ratio-
LOWHIGH
Day Range3.67
4.07
52 Week Range1.52
16.92
Ratios
EPS-15.59

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Senti Biosciences (SNTI)

Senti Biosciences, Inc. (SNTI) is a biotechnology company focused on developing cell and gene therapies using its proprietary gene circuit technology. The company's technology enables precise control of gene expression in cells, allowing for the engineering of cells that can perform specific functions in the body. Senti Biosciences aims to harness the power of these engineered cells to treat a wide range of diseases, including cancer and genetic disorders.
One of the key advantages of Senti Biosciences' gene circuit technology is its ability to create 'programmable' cells. These cells can be designed to respond to specific signals in the body, such as the presence of a tumor or a disease-causing gene mutation. Once activated, the cells can produce therapeutic molecules or carry out other therapeutic functions to combat the disease. This approach offers a potentially more targeted and effective treatment option compared to traditional therapies.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Timothy K. Lu M.D., Ph.D.
Headquarters
South San Francisco
Employees
122
Exchange
NASDAQ
add Senti Biosciences to watchlist

Keep an eye on Senti Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Senti Biosciences's (SNTI) price per share?

The current price per share for Senti Biosciences (SNTI) is $3.93. The stock has seen a price change of $0.04 recently, indicating a 1.03% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Senti Biosciences (SNTI)?

For Senti Biosciences (SNTI), the 52-week high is $16.93, which is 330.66% from the current price. The 52-week low is $1.52, the current price is 158.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Senti Biosciences (SNTI) a growth stock?

Senti Biosciences (SNTI) has shown an average price growth of -2.21% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Senti Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Senti Biosciences (SNTI) stock price performance year to date (YTD)?

As of the latest data, Senti Biosciences (SNTI) has a year-to-date price change of 11.97%. Over the past month, the stock has experienced a price change of -28.28%. Over the last three months, the change has been 82.79%. Over the past six months, the figure is 25.4%.
help

Is Senti Biosciences (SNTI) a profitable company?

Senti Biosciences (SNTI) has a net income of -$71.06M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -18.02K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.56M, although specific revenue growth data is currently not available. Operating income is noted at -$92.73M. Furthermore, the EBITDA is -$56.6M.
help

What is the market capitalization of Senti Biosciences (SNTI)?

Senti Biosciences (SNTI) has a market capitalization of $18.03M. The average daily trading volume is 3.9, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level